Gurugram (Haryana) [India], July 11: Positive Mind Care & Research Centre welcomes the landmark judgment reaffirming that mental health conditions must receive the same insurance coverage as physical illnesses. The decision marks another significant step towards ensuring that mental healthcare is treated as an essential component of overall healthcare, in line with the provisions of the Mental Healthcare Act, 2017.
The ruling reiterates that denying insurance claims solely because treatment relates to a mental illness is inconsistent with the principle of parity established under Indian law. It strengthens the rights of millions of individuals living with depression, anxiety disorders, obsessive-compulsive disorder (OCD), bipolar disorder, schizophrenia, and other mental health conditions by reinforcing their entitlement to equitable health insurance benefits.
Speaking on the development, Ms. Sandra Srivastava, CEO & Founder, Positive Mind Care & Research Centre, said:
“This judgment is more than a legal victory; it is a victory for dignity, equality, and accessible healthcare. Mental illnesses are real, treatable medical conditions, and individuals seeking treatment should never be discriminated against by insurance providers. Equal insurance coverage will encourage early intervention, reduce financial barriers, and ultimately improve mental health outcomes across the country.”
Mental health disorders affect millions of Indians, yet delayed treatment often results from stigma, lack of awareness, and financial constraints. Insurance coverage plays a vital role in enabling individuals and families to seek timely, evidence-based care without the added burden of high treatment costs.
As mental healthcare continues to advance, innovative treatment options are transforming the way mental illnesses are managed. FDA-approved Deep Transcranial Magnetic Stimulation (Deep TMS
) is a revolutionary, non-invasive, drug-free, safe, and clinically proven treatment for conditions such as Major Depressive Disorder and Obsessive-Compulsive Disorder (OCD), along with other indications for which it has received regulatory approval. Deep TMS stimulates targeted brain regions using magnetic pulses without surgery or anesthesia, enabling patients to resume their daily activities immediately after treatment. Positive Mind Care & Research Centre is proud to be a pioneer in introducing this revolutionary treatment in India. By integrating AI-enabled technologies with evidence-based clinical care with FDA-approved Deep TMS, Positive Mind Care has established itself as India’s leading next-generation mental healthcare clinic, delivering personalized, technology-driven, evidence-based mental healthcare solutions.
Positive Mind Care & Research Centre believes this judgment will:
• Strengthen implementation of the Mental Healthcare Act, 2017.
• Encourage insurers to ensure compliance with mental health parity requirements.
• Increase public awareness of patients’ legal rights.
• Improve access to counselling, psychiatric consultations, psychotherapy, and evidence-based treatments.
• Help reduce stigma by recognizing mental health as equally important as physical health.
• Encourage individuals to seek timely treatment without fear of financial burden.
About Positive Mind Care & Research Centre
Positive Mind Care & Research Centre is dedicated to providing comprehensive mental healthcare through psychological counselling, psychiatric services, psychological assessments, innovative treatment approaches, community awareness programmes, research, AI-driven mental health solutions, and FDA-approved Deep TMS. The organization is committed to making advanced, evidence-based mental healthcare accessible to all.
Media Contact
Sandra Srivastava
Founder & CEO
Positive Mind Care & Research Centre
Email: info@positivemindcare.com
Website: positivemindcare.com
If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.
